| Fungal Infection |
1 |
1 |
| Skin and Soft Tissue Infection |
0 |
0.9 |
| Candidiasis |
0 |
0.89 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Vulvovaginal Candidiasis |
0 |
0.56 |
| Vaginal Discharge |
0 |
0.29 |
| Vagina |
0 |
0.28 |
| Adverse Effects |
0 |
0.14 |
| Antifungal |
0 |
0.14 |
| Burns |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Nausea |
0 |
0.14 |
| Pain |
0 |
0.14 |
| Headache |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Pain Management |
0 |
0.11 |
| Patient Safety |
0 |
0.11 |
| Pregnancy |
0 |
0.11 |
| Wound Management |
0 |
0.11 |